What are Nutex Health Inc.'s total assets?

Nutex Health Inc. (NUTX) holds $957.3M in total assets, up 25.7% year over year.

How much debt does Nutex Health Inc. have?

Nutex Health Inc. carries $348.9M in total debt against $346.3M of shareholders' equity, a debt-to-equity ratio of 1.01.

How much cash does Nutex Health Inc. have?

Nutex Health Inc. holds $210.6M in cash and equivalents.

Can Nutex Health Inc. cover its short-term obligations?

Its current ratio is 3.14 — current assets exceed current liabilities.

Where does Nutex Health Inc.'s balance sheet data come from?

Every line is extracted from Nutex Health Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Nutex Health Inc. NUTX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$210.64M+13.3%	$185.87M+11.9%	$166.05M+71.7%	$96.73M+14.2%	$84.73M+108%
Restricted cash	$3.29M+1,008%	$297K—	$0—	——	——
Inventories	$4.68M+63.3%	$2.87M-9.2%	$3.16M+38.8%	$2.28M-27.0%	$3.12M+9.4%
Prepaid expenses and other current assets	$18.43M-25.2%	$24.66M+48.7%	$16.59M-13.0%	$19.06M+67.4%	$11.39M+13.9%
Total current assets	$579.65M+7.6%	$538.81M-9.1%	$592.65M+25.3%	$473.03M+17.8%	$401.52M+37.3%
Property and equipment, net	$94.93M+0.4%	$94.58M+14.2%	$82.82M-0.1%	$82.92M+8.5%	$76.43M-1.9%
Accumulated depreciation	$33.6M—	——	——	——	——
Operating lease right-of-use assets	$26.55M-1.5%	$26.96M-1.5%	$27.35M-1.4%	$27.75M+1.0%	$27.47M-1.5%
Goodwill	$13.92M0.0%	$13.92M0.0%	$13.92M0.0%	$13.92M0.0%	$13.92M0.0%
Intangible assets, net	$13.91M-2.3%	$14.23M-2.2%	$14.56M-2.2%	$14.88M-2.1%	$15.21M-2.1%
Deferred tax assets	$45.05M-4.9%	$47.38M+23.7%	$38.29M+43.2%	$26.74M+60.2%	$16.69M+48.3%
Other non-current assets	$668K+0.9%	$662K+32.7%	$499K+73.3%	$288K-58.7%	$698K-1.8%
Total assets	$957.32M+4.2%	$918.53M-4.8%	$964.52M+14.7%	$841.03M+10.4%	$761.92M+16.3%
Accrued expenses	$32.5M+21.4%	$26.77M-3.9%	$27.87M+1.2%	$27.53M+11.7%	$24.64M-3.1%
Accrued compensation	$16.99M—	——	——	——	——
Current portion of long-term debt	$16.73M+25.4%	$13.34M-25.9%	$18M-5.0%	$18.95M+39.0%	$13.64M-5.3%
Operating lease liabilities, current	$2.18M+1.1%	$2.15M+1.9%	$2.11M+1.1%	$2.09M-0.8%	$2.1M+1.1%
Finance Lease Liability, Current	$7.36M+4.1%	$7.08M-0.4%	$7.11M+0.5%	$7.07M-11.9%	$8.03M+4.2%
Income taxes payable	$15.59M+1,699%	$867K—	$0—	——	——
Total current liabilities	$184.44M+16.8%	$157.91M-14.9%	$185.46M-4.8%	$194.87M+10.4%	$176.57M+14.5%
Long-term debt	$24.26M-16.8%	$29.17M+14.1%	$25.57M+25.0%	$20.46M-5.8%	$21.73M-3.3%
Operating lease liabilities, non-current	$29.63M-1.3%	$30.04M-1.3%	$30.42M-1.2%	$30.81M+1.5%	$30.35M-0.9%
Finance lease liabilities	$268.78M0.0%	$268.88M-0.4%	$270.08M+4.7%	$258.01M-0.1%	$258.39M-0.4%
Total liabilities	$515.27M+4.1%	$495.09M-6.0%	$526.49M+4.4%	$504.15M+3.5%	$487.04M+4.3%
Common stock	950M0.0%	950M0.0%	950M0.0%	950M+15,833,233%	6K0.0%
Additional paid-in capital	$585.67M-4.9%	$615.63M+0.1%	$615.18M+4.5%	$588.7M+9.1%	$539.36M+10.2%
Retained earnings	-$239.38M+16.4%	-$286.19M+4.0%	-$298.02M+15.7%	-$353.46M-3.3%	-$342.26M+4.1%
Noncontrolling interests	$95.76M+1.9%	$93.99M-22.2%	$120.87M+18.9%	$101.63M+30.7%	$77.77M+38.6%
Total stockholders' equity	$346.29M+5.1%	$329.45M+3.9%	$317.17M+34.8%	$235.25M+19.4%	$197.11M+48.8%
Total liabilities and stockholders' equity	$957.32M+4.2%	$918.53M-4.8%	$964.52M+14.7%	$841.03M+10.4%	$761.92M+16.3%
Deferred Tax Assets and Other Non-Current Assets	$668K—	——	——	——	——
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——	——
Finite Lived Intangible Assets - Gross	——	——	——	——	——
Intangible Assets Gross (Excluding Goodwill)	$25.97M—	——	——	——	——
Net Investment in Lease	$26.55M-1.5%	$26.96M-1.5%	$27.35M-1.4%	$27.75M+1.0%	$27.47M-1.5%
Intangible assets — net	$13.91M—	——	——	——	——
Other intangible assets—net	$20.91M-1.5%	$21.23M-1.5%	$21.56M+44.9%	$14.88M-2.1%	$15.21M-2.1%
Operating lease right-of-use assets	$26.55M-1.5%	$26.96M-1.5%	$27.35M-1.4%	$27.75M+1.0%	$27.47M-1.5%
Other non-current assets	$668K—	——	——	——	——
Property, plant and equipment at cost	$128.53M—	——	——	——	——
Operating Lease Right-of-Use Assets in Other Assets	$26.55M-1.5%	$26.96M-1.5%	$27.35M-1.4%	$27.75M+1.0%	$27.47M-1.5%
Software and Technology Licenses, Net	$668K—	——	——	——	——
Accrued Litigation	$56.83M+14.3%	$49.74M-22.7%	$64.31M—	——	——
Accrued expenses and other current liabilities	$32.5M—	——	——	——	——
Revolving credit facility	$146K-80.3%	$740K-86.0%	$5.3M-32.5%	$7.86M+10.3%	$7.13M+101%
Deferred Compensation Liability (Current)	$2.72M—	——	——	——	——
Line of Credit Outstanding	$146K-80.3%	$740K-86.0%	$5.3M-32.5%	$7.86M+10.3%	$7.13M+101%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$211K—	——	——	——	——
Accrued expenses and other liabilities	$32.5M—	——	——	——	——
Accrued litigation	$56.83M+14.3%	$49.74M-22.7%	$64.31M—	——	——
Total debt	$348.94M-0.5%	$350.65M-0.7%	$353.3M+4.7%	$337.39M+0.9%	$334.24M-0.7%
Total Carrying Value of Debt	$41.35M—	——	——	——	——
Common Stock Par Value Per Share	$0.00—	——	——	——	——
Common Stock Shares Issued	7M—	——	——	——	——
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$7K0.0%	$7K0.0%	$7K0.0%	$7K+16.7%	$6K0.0%
Warrants and Rights Outstanding	——	——	——	——	——
Cumulative Cost Basis	$128.53M—	——	——	——	——
Line of Credit Remaining Borrowing Capacity	——	——	——	——	——
Number Exercisable (in shares)	——	——	——	——	——
Class of Warrant or Right, Outstanding	——	——	——	——	——
Common stock, par value (in dollars per share)	$0—	——	——	——	——
Common stock, shares authorized (in shares)	$950M—	——	——	——	——
Common stock, shares issued (in shares)	$6.95M—	——	——	——	——
Common Stock, Shares, Outstanding	$6.95M—	——	——	——	——
Long-term debt, gross	$41.35M—	——	——	——	——
Deferred income taxes	——	——	——	——	——
Current maturities of long-term debt	$7.36M+4.1%	$7.08M-0.4%	$7.11M+0.5%	$7.07M-11.9%	$8.03M+4.2%
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$220.7M-0.8%	$222.37M-1.5%	$225.72M+4.8%	$215.4M-0.4%	$216.19M-1.2%
Finite-Lived Intangible Assets, Accumulated Amortization	$5.06M—	——	——	——	——
2028	——	——	——	——	——
2030	——	——	——	——	——
Thereafter	——	——	——	——	——
Remainder of 2026	——	——	——	——	——
2027	——	——	——	——	——
2029	——	——	——	——	——
Gross Carrying Amount	——	——	——	——	——
Indefinite- lived intangible impairment	$25.97M—	——	——	——	——
Accrued medical claims	$5.54M—	——	——	——	——
Noncontrolling interests in subsidiaries	$95.76M+1.9%	$93.99M-22.2%	$120.87M+18.9%	$101.63M+30.7%	$77.77M+38.6%
Number of contract doctors	——	——	——	——	——
Number of hospital facilities	——	——	——	——	——
Partner with physicians	——	——	——	——	——
Number of states the company operates within	——	——	——	——	——
Other accrued liabilities	$1.76M+2.7%	$1.72M+203%	$566K-59.9%	$1.41M-94.3%	$24.64M+919%
Accrued supplier expenses	$6.29M—	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Nutex Health Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Nutex Health Inc.'s total assets?: Nutex Health Inc. (NUTX) holds $957.3M in total assets, up 25.7% year over year.
How much debt does Nutex Health Inc. have?: Nutex Health Inc. carries $348.9M in total debt against $346.3M of shareholders' equity, a debt-to-equity ratio of 1.01.
How much cash does Nutex Health Inc. have?: Nutex Health Inc. holds $210.6M in cash and equivalents.
Can Nutex Health Inc. cover its short-term obligations?: Its current ratio is 3.14 — current assets exceed current liabilities.
Where does Nutex Health Inc.'s balance sheet data come from?: Every line is extracted from Nutex Health Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.